FFCP PHASE1:Mm9::chr11:99809734..99809743,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=435286|HGNC=|MCL_coexpression_id=25|UniProt=A2A5X3|association_with_transcript=-45bp_to_ENSMUST00000105052,NM_001085527,uc007ljy.1_5end|description=CAGE_peak_1_at_Krtap9-5_5end|id=chr11:99809734..99809743,+|ontology_enrichment_celltype=CL:0000115!1.55e-13!1;CL:0000213!1.55e-13!1;CL:0002078!1.55e-13!1;CL:0002262!1.55e-13!1;CL:1000398!1.55e-13!1|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000014!1.84e-40!5;UBERON:0001003!1.84e-40!5;UBERON:0002097!1.84e-40!5;UBERON:0002199!1.84e-40!5;UBERON:0007029!1.84e-40!5;UBERON:0007376!1.84e-40!5;UBERON:0002416!1.84e-40!5;UBERON:0007383!1.84e-40!5;UBERON:0000353!1.55e-13!1;UBERON:0003497!1.55e-13!1;UBERON:0003909!1.55e-13!1;UBERON:0003835!1.55e-13!1;UBERON:0003513!1.55e-13!1;UBERON:0001281!1.55e-13!1;UBERON:0001280!1.55e-13!1;UBERON:0004647!1.55e-13!1;UBERON:0003102!3.08e-09!23|ontology_enrichment_uberon_v019_2=UBERON:0000014,1.64e-52,5;UBERON:0001003,1.64e-52,5;UBERON:0002097,1.64e-52,5;UBERON:0002199,1.64e-52,5;UBERON:0007029,1.64e-52,5;UBERON:0007376,1.64e-52,5;UBERON:0002416,1.64e-52,5;UBERON:0007383,1.64e-52,5;UBERON:0003102,6.90e-13,22|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.289864488701678,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.7436204235731,0,0.180938774784468,4.65552141612232,111.615811826642,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.441182838239031,0.463735671240843|short_description=p1@Krtap9-5}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:435286 | |||
|HGNC= | |||
|MCL_coexpression_id=25 | |||
|TSSclassifier=NA | |||
|UniProt=uniprot:A2A5X3 | |||
|association_with_transcript=-45bp_to_ENSMUST00000105052,NM_001085527,uc007ljy.1_5end | |||
|cluster_id=chr11:99809734..99809743,+ | |||
|description=CAGE_peak_1_at_Krtap9-5_5end | |||
|id=chr11:99809734..99809743,+ | |||
|ontology_enrichment_celltype=CL:0000115!1.55e-13!1;CL:0000213!1.55e-13!1;CL:0002078!1.55e-13!1;CL:0002262!1.55e-13!1;CL:1000398!1.55e-13!1 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000014!1.84e-40!5;UBERON:0001003!1.84e-40!5;UBERON:0002097!1.84e-40!5;UBERON:0002199!1.84e-40!5;UBERON:0007029!1.84e-40!5;UBERON:0007376!1.84e-40!5;UBERON:0002416!1.84e-40!5;UBERON:0007383!1.84e-40!5;UBERON:0000353!1.55e-13!1;UBERON:0003497!1.55e-13!1;UBERON:0003909!1.55e-13!1;UBERON:0003835!1.55e-13!1;UBERON:0003513!1.55e-13!1;UBERON:0001281!1.55e-13!1;UBERON:0001280!1.55e-13!1;UBERON:0004647!1.55e-13!1;UBERON:0003102!3.08e-09!23 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000014,1.64e-52,5;UBERON:0001003,1.64e-52,5;UBERON:0002097,1.64e-52,5;UBERON:0002199,1.64e-52,5;UBERON:0007029,1.64e-52,5;UBERON:0007376,1.64e-52,5;UBERON:0002416,1.64e-52,5;UBERON:0007383,1.64e-52,5;UBERON:0003102,6.90e-13,22 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.289864488701678,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,23.7436204235731,0,0.180938774784468,4.65552141612232,111.615811826642,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.441182838239031,0.463735671240843 | |||
|short_description=p1@Krtap9-5 | |||
}} |
Revision as of 13:37, 4 August 2015
Short description: | p1@Krtap9-5 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_1_at_Krtap9-5_5end |
Coexpression cluster: | MCL_coexpression_mm9:25 |
Association with transcript: | -45bp_to_ENSMUST00000105052, NM_001085527, uc007ljy.1_5end |
EntrezGene: | 435286 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
zone of skin | 1.64e-52 | 5 |
skin epidermis | 1.64e-52 | 5 |
skin of body | 1.64e-52 | 5 |
integument | 1.64e-52 | 5 |
surface | 1.64e-52 | 5 |
outer epithelium | 1.64e-52 | 5 |
integumental system | 1.64e-52 | 5 |
enveloping layer of ectoderm | 1.64e-52 | 5 |
surface structure | 6.90e-13 | 22 |